Semasize 0.25 Milligram Prefilled Syringe 0.19 Millilitre

AboutSemasize 0.25 Milligram Prefilled Syringe contains semaglutide, a glucagon-like peptide-1 receptor agonist prescribed for selected patients with type 2 diabetes or weight-management indications, according to the approved product and clinician’s advice.Usage InstructionsFor subcutaneous injection only and administration by a trained patient or healthcare professional. Use once weekly on the same day as prescribed. Follow the supplied instructions for injection-site rotation and disposal of the syringe. Do not share the device.BenefitsHelps improve blood glucose control and may support weight reduction when used with an appropriate diet, physical activity and medical programme.How it WorksSemaglutide mimics a natural gut hormone, increasing glucose-dependent insulin release, reducing glucagon secretion, slowing gastric emptying and helping regulate appetite.Side EffectsNausea, vomiting, diarrhoea, constipation, abdominal pain or reduced appetite may occur, especially during dose escalation. Seek urgent care for severe persistent abdominal pain, dehydration, allergic symptoms or symptoms of gallbladder disease.Safety AdvicePrescription and cold-chain medicine. Do not use without specialist advice. Tell the doctor about pancreatitis, gallbladder disease, diabetic eye disease, kidney disease, pregnancy, breastfeeding and all medicines. It is not a substitute for insulin in type 1 diabetes or diabetic ketoacidosis.StorageStore in a refrigerator at 2°C to 8°C. Do not freeze or expose to direct light. Keep in the original carton and use an approved insulated transport system. Follow the pack leaflet for exact in-use storage limits.